Search

Author/Creator Fehm, Tanja

1. 2022-RA-296-ESGO Non-pharmacological, patient-related predictive model for the occurrence of CINV: prospective, multicentre study in Germany (NOGGO-EMRISK trial). (20th October 2022)

Authors:
Sehouli, Jalid; Oskay-Özcelik, Gülten; Zocholl, Dario; Klemt, Anna-Sophia; Bangemann, Nikola; Albrecht, Oliver; Strittmatter, Hans-Joachim; Wimberger, Pauline; Kaczerowsky, Anna; Lorenz, Ralf; Ruhwedel, Wencke; Fehm, Tanja; Zahn, Andreas; Tomé, Oliver; Markert, Miriam; Hager, Dietrich; Zorr, Andr...
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A453
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 2022-RA-835-ESGO AGO-OVAR 2.34/MIROVA: A randomized phase II trial of Mirvetuximab soravtansine (IMGN853), in folate receptor alpha (FRα) high recurrent ovarian cancer eligible for platinum-based chemotherapy. (20th October 2022)

Authors:
Trillsch, Fabian; Schochter, Fabienne; Park-Simon, Tjoung-Won; Reuß, Alexander; Fehm, Tanja; Wimberger, Pauline; Bronger, Holger; Schmalfeldt, Barbara; Sehouli, Jalid; Marmé, Frederik; Heitz, Florian; Mahner, Sven; Fredrich, Michaela; Barth, Stefanie; Stec, James; Method, Michael; Harter, Philipp
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A268
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 295 Accumulation of 53BP1 in circulating tumor cells during treatment with eribulin identifies chemotherapy-responsive metastatic breast cancer patients. (4th December 2020)

Authors:
Schochter, Fabienne; Werner, Kim; Köstler, Cäcilia; Müller, Volkmar; Neubauer, Hans; Fehm, Tanja; Friedl, Thomas WP; Polzer, Bernhard; Janni, Wolfgang; Wiesmüller, Lisa
Journal:
International journal of gynecological cancer
Issue:
Volume 30(2020)Supplement 4
Page Start:
A98
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 86: Predictive Factors of Survival After Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast Cancer. (October 2021)

Authors:
Matuschek, Christiane; Budach, Wilfried; Tamaskovics, Balint; Fischer, Johannes; Boelke, Edwin; Corradini, Stefanie; Kammers, Kai; Kraemling, Carolin Nestle; Fehm, Tanja; Wollandt, Sylvia; Speer, Vanessa; Haussmann, Jan
Journal:
Radiotherapy and oncology
Issue:
Volume 163(2021)Supplement 1
Page Start:
S38
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. A Phase II Study of Metronomic Daily Oral Vinorelbine as First-Line Chemotherapy in Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast Cancer Resistant to Endocrine Therapy: Vinometro. (November 2017)

Authors:
Thomssen, Christoph; Decker, Thomas; Fehm, Tanja; Fuxius, Stefan; Harbeck, Nadia; Juhasz-Böss, Ingolf; Möbus, Volker; Seehase, Martina; Schollenberger, Lukas; Ruckes, Christian; Schmidt, Marcus
Journal:
Breast
Issue:
Volume 36(2017)Supplement 1
Page Start:
S51
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Acute hepatitis C virus infection induces anti‐host cell receptor antibodies with virus‐neutralizing properties. Issue 3 (28th July 2015)

Authors:
Tawar, Rajiv G.; Colpitts, Che C.; Timm, Jörg; Fehm, Tanja; Roggendorf, Michael; Meisel, Helga; Meyer, Nicolas; Habersetzer, François; Cosset, François‐Loïc; Berg, Thomas; Zeisel, Mirjam B.; Baumert, Thomas F.
Journal:
Hepatology
Issue:
Volume 62:Issue 3(2015:Sep.)
Page Start:
726
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Alterations of the RANKL pathway in blood and bone marrow samples of prostate cancer patients without bone metastases. Issue 2 (19th June 2012)

Authors:
Todenhöfer, Tilman; Hennenlotter, Jörg; Schmiedel, Benjamin Joachim; Hohneder, Andrea; Grimm, Sabrina; Kühs, Ursula; Salih, Helmut Rainer; Bühring, Hans‐Jörg; Fehm, Tanja; Gakis, Georgios; Blumenstock, Gunnar; Aufderklamm, Stefan; Schilling, David; Stenzl, Arnulf; Schwentner, Christian
Journal:
Prostate
Issue:
Volume 73:Issue 2(2013)
Page Start:
162
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial. Issue 5 (May 2020)

Authors:
Pfisterer, Jacobus; Shannon, Catherine M; Baumann, Klaus; Rau, Joern; Harter, Philipp; Joly, Florence; Sehouli, Jalid; Canzler, Ulrich; Schmalfeldt, Barbara; Dean, Andrew P; Hein, Alexander; Zeimet, Alain G; Hanker, Lars C; Petit, Thierry; Marmé, Frederik; El-Balat, Ahmed; Glasspool, Rosalind; de...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 5(2020)
Page Start:
699
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗